Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1087
-
Total 13F shares, excl. options
-
224M
-
Shares change
-
+2.24M
-
Total reported value, excl. options
-
$59B
-
Value change
-
+$722M
-
Put/Call ratio
-
1.14
-
Number of buys
-
507
-
Number of sells
-
-456
-
Price
-
$262.98
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2020
1,212 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2020.
Elevance Health, Inc. - Common Stock (ELV) has 1,087 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 224M shares
of 226M outstanding shares and own 99.32% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.7M shares), VANGUARD GROUP INC (19.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.2M shares), STATE STREET CORP (11.1M shares), WELLINGTON MANAGEMENT GROUP LLP (10.5M shares), FMR LLC (7.98M shares), Capital International Investors (7.52M shares), Invesco Ltd. (4.67M shares), NORDEA INVESTMENT MANAGEMENT AB (4.61M shares), and BAILLIE GIFFORD & CO (4.1M shares).
This table shows the top 1087 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.